相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer
Melissa Javellana et al.
CANCER RESEARCH (2022)
BMP2-induction of FN14 promotes protumorigenic signaling in gynecologic cancer cells
Tomohiko Fukuda et al.
CELLULAR SIGNALLING (2021)
Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
Mikella Robinson et al.
CANCERS (2021)
Epigenetic Therapy Augments Classic Chemotherapy in Suppressing the Growth of 3D High-Grade Serous Ovarian Cancer Spheroids over an Extended Period of Time
Michelle Bilbao et al.
BIOMOLECULES (2021)
CellProfiler 4: improvements in speed, utility and usability
David R. Stirling et al.
BMC BIOINFORMATICS (2021)
Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine
Jin Qian et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Small Molecule Targeting of Oxysterol-Binding Protein (OSBP)-Related Protein 4 and OSBP Inhibits Ovarian Cancer Cell Proliferation in Monolayer and Spheroid Cell Models
Ryan C. Bensen et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis
Yinu Wang et al.
CANCER RESEARCH (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
Nastassja Terraneo et al.
FRONTIERS IN ONCOLOGY (2020)
Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model
Brittney S. Harrington et al.
CANCERS (2020)
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval
Kimberly R. Jordan et al.
CLINICAL CANCER RESEARCH (2020)
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis
Demetra H. Hufnagel et al.
BIOMARKER RESEARCH (2020)
Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems
Bishnubrata Patra et al.
PLOS ONE (2020)
NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients
Jun-yan Liu et al.
CELL DEATH & DISEASE (2019)
Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation
An-Yue Wu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Mechanical Roles of F-Actin in the Differentiation of Stem Cells: A Review
Yan-Lei Fan et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2019)
A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
Nerea Mendez-Barbero et al.
EBIOMEDICINE (2019)
Tumor-associated macrophages promote the metastasis of ovarian carcinoma cells by enhancing CXCL16/CXCR6 expression
Lan Hong et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Noncanonical NF-kappa B in Cancer
Matthew Tegowski et al.
BIOMEDICINES (2018)
IL-6 mediates platinum -induced enrichment of ovarian cancer stem cells
Yinu Wang et al.
JCI INSIGHT (2018)
NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells
Carrie D. House et al.
CANCER RESEARCH (2017)
Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure
Elke Pogge von Strandmann et al.
TRENDS IN CANCER (2017)
The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics
J. G. Perez et al.
ONCOGENE (2016)
Characterization of ovarian cancer cell lines as in vivo models for preclinical studies
Lidia Hernandez et al.
GYNECOLOGIC ONCOLOGY (2016)
Biphasic Regulation of Yes-associated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelial Cells: A NOVEL ROLE FOR PROTEIN KINASE D (PKD)
Jia Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells
Yukinari Itoigawa et al.
RESPIRATORY RESEARCH (2015)
Mcl-1 Mediates TWEAK/Fn14-Induced Non-Small Cell Lung Cancer Survival and Therapeutic Response
Timothy G. Whitsett et al.
MOLECULAR CANCER RESEARCH (2014)
NF-κB Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-κB, Contributes to Ovarian Cancer Progression
Masaya Uno et al.
PLOS ONE (2014)
Stem cell differentiation increases membrane-actin adhesion regulating cell blebability, migration and mechanics
Kristina Sliogeryte et al.
SCIENTIFIC REPORTS (2014)
Role of theTWEAK-Fn14-cIAP1-NF-κB signaling axis in the regulation of myogenesis anc muscle homeostasis
Emeka K. Enwere et al.
FRONTIERS IN IMMUNOLOGY (2014)
Ovarian cancer stem cells: Working towards the root of sternness
Rosemary Foster et al.
CANCER LETTERS (2013)
The Rise of Soluble TWEAK Levels in Severely Obese Subjects After Bariatric Surgery May Affect Adipocyte-Cytokine Production Induced by TNFα
Elsa Maymo-Masip et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling
Thomas G. Bird et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TWEAK: a new player obesity and diabetes
Joan Vendrell et al.
FRONTIERS IN IMMUNOLOGY (2013)
TWEAK/Fn14 axis-targeted therapeutics: moving basic science discoveries to the clinic
Emily Cheng et al.
FRONTIERS IN IMMUNOLOGY (2013)
Ovarian cancer stem cell markers: Prognostic and therapeutic implications
Daniela Burgos-Ojeda et al.
CANCER LETTERS (2012)
IKK-ε Coordinates Invasion and Metastasis of Ovarian Cancer
Sarah Hsu et al.
CANCER RESEARCH (2012)
Annotated high-throughput microscopy image sets for validation
Vebjorn Ljosa et al.
NATURE METHODS (2012)
Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
Lijing Luo et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
Linda C. Burkly et al.
IMMUNOLOGICAL REVIEWS (2011)
TWEAK, a multifunctional cytokine in kidney injury
Ana Belen Sanz et al.
KIDNEY INTERNATIONAL (2011)
Nuclear Factor κB Transcription Factors Are Coexpressed and Convey a Poor Outcome in Ovarian Cancer
Christina M. Annunziata et al.
CANCER (2010)
TWEAK promotes ovarian cancer cell metastasis via NF-κB pathway activation and VEGF expression
Lan Dai et al.
CANCER LETTERS (2009)
IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis
Julia Bollrath et al.
EMBO REPORTS (2009)
NF-κB as a Critical Link Between Inflammation and Cancer
Michael Karin
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
The TWEAK - Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting
Jeffrey A. Winkles
NATURE REVIEWS DRUG DISCOVERY (2008)
Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells
R. Chen et al.
ONCOGENE (2008)
TWEAKing tissue remodeling by a multifunctional cytokine: Role of TWEAK/Fn14 pathway in health and disease
Linda C. Burkly et al.
CYTOKINE (2007)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
Role of TWEAK and Fn14 in tumor biology
Jeffrey A. Winkles et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-κB and degradation of MyoD protein
C Dogra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
TWEAK attenuates the transition from innate to adaptive immunity
H Maecker et al.
CELL (2005)
Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK
T Hagemann et al.
JOURNAL OF IMMUNOLOGY (2005)
TWEAK induces NF-κB2 p100 processing and long lasting NF-κB activation
T Saitoh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Involvement of TWEAK in interferon γ-stimulated monocyte cytotoxicity
M Nakayama et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
